QIAGEN N.V.
QGEN
$40.71
-$0.73-1.76%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 2.36% | 5.46% | 0.30% | -5.48% | 2.24% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.36% | 5.46% | 0.30% | -5.48% | 2.24% |
| Cost of Revenue | -3.35% | 5.79% | 167.87% | -6.28% | 7.24% |
| Gross Profit | 5.41% | 5.29% | -84.77% | -5.08% | -0.23% |
| SG&A Expenses | -2.91% | 0.39% | -1.52% | -6.02% | -5.36% |
| Depreciation & Amortization | -18.23% | -14.31% | -4.50% | 0.65% | -10.64% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.82% | 1.02% | 72.44% | -5.83% | 0.70% |
| Operating Income | 18.92% | 20.73% | -240.62% | -4.17% | 7.50% |
| Income Before Tax | 5.87% | 16.65% | -318.39% | -5.97% | 12.32% |
| Income Tax Expenses | 76.93% | -16.41% | -285.75% | -8.99% | 24.83% |
| Earnings from Continuing Operations | -9.57% | 26.01% | -327.09% | -5.13% | 9.93% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.57% | 26.01% | -327.09% | -5.13% | 9.93% |
| EBIT | 18.92% | 20.73% | -240.62% | -4.17% | 7.50% |
| EBITDA | 9.71% | 13.72% | -164.76% | -1.30% | 2.85% |
| EPS Basic | -9.74% | 25.50% | -326.36% | -6.32% | 9.73% |
| Normalized Basic EPS | 14.51% | 21.29% | -239.63% | -9.00% | 16.97% |
| EPS Diluted | -9.77% | 25.55% | -330.05% | -5.63% | 8.90% |
| Normalized Diluted EPS | 14.51% | 21.60% | -241.08% | -9.02% | 16.97% |
| Average Basic Shares Outstanding | 0.19% | 0.41% | 0.30% | 1.26% | 0.17% |
| Average Diluted Shares Outstanding | 0.19% | 0.15% | -0.72% | 1.29% | 0.17% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |